These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28110132)

  • 21. Characterization of the hypercoagulable state in patients with sickle cell disease.
    Shah N; Thornburg C; Telen MJ; Ortel TL
    Thromb Res; 2012 Nov; 130(5):e241-5. PubMed ID: 22959127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboelastography Values Remain Hypercoagulative 6 Months After Obesity Surgery: a Pilot Study.
    Tuovila M; Erkinaro T; Koivukangas V; Savolainen ER; Laurila P; Ohtonen P; Ala-Kokko T
    Obes Surg; 2018 Dec; 28(12):3943-3949. PubMed ID: 30083792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemostatic abnormalities in dogs with carcinoma: a thromboelastographic characterization of hypercoagulability.
    Vilar Saavedra P; Lara García A; Zaldívar López S; Couto G
    Vet J; 2011 Nov; 190(2):e78-e83. PubMed ID: 21454111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hemostasis system in children with hereditary spherocytosis.
    Seregina EA; Poletaev AV; Bondar EV; Vuimo TA; Ataullakhanov FI; Smetanina NS
    Thromb Res; 2019 Apr; 176():11-17. PubMed ID: 30763822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triglyceride/HDL-cholesterol ratio and plasminogen activator inhibitor-1 independently predict high pulse pressure in sickle cell trait and disease.
    Olabode OP; Akinlade OM; Babatunde AS; Abdulazeez MI; Biliaminu SA; Oyabambi AO; Olatunji VA; Soladoye AO; Olatunji LA
    Arch Physiol Biochem; 2020 May; 126(2):166-171. PubMed ID: 30145922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemostatic abnormalities in sickle cell disease.
    Lim MY; Ataga KI; Key NS
    Curr Opin Hematol; 2013 Sep; 20(5):472-7. PubMed ID: 23817169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Bone in Sickle Cell Trait and Sickle Cell Disease Female Mice Is Associated With Reduced IGF-1 in Bone and Serum.
    Xiao L; Andemariam B; Taxel P; Adams DJ; Zempsky WT; Dorcelus V; Hurley MM
    Endocrinology; 2016 Aug; 157(8):3036-46. PubMed ID: 27171384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
    Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insertion of central venous catheters induces a hypercoagulable state.
    Ryan ML; Thorson CM; King DR; Van Haren RM; Manning RJ; Andrews DM; Livingstone AS; Proctor KG
    J Trauma Acute Care Surg; 2012 Aug; 73(2):385-90. PubMed ID: 22846944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sickle cell disease is associated with iron mediated hypercoagulability.
    Shah N; Welsby IJ; Fielder MA; Jacobsen WK; Nielsen VG
    J Thromb Thrombolysis; 2015 Aug; 40(2):182-5. PubMed ID: 25986992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability?
    De Pietri L; Montalti R; Begliomini B; Scaglioni G; Marconi G; Reggiani A; Di Benedetto F; Aiello S; Pasetto A; Rompianesi G; Gerunda GE
    Eur J Anaesthesiol; 2010 Jul; 27(7):608-16. PubMed ID: 20389262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease.
    Qari MH; Dier U; Mousa SA
    Clin Appl Thromb Hemost; 2012; 18(2):195-200. PubMed ID: 21949038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudden Death in Diabetic Ketoacidosis Complicated by Sickle Cell Trait.
    Dau GE; Shah JJ; Walsh JC; Berran PJ
    Am J Forensic Med Pathol; 2022 Sep; 43(3):277-281. PubMed ID: 35135968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
    Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboelastography is a suboptimal test for determination of the underlying cause of bleeding associated with cardiopulmonary bypass and may not predict a hypercoagulable state.
    Welsh KJ; Padilla A; Dasgupta A; Nguyen AN; Wahed A
    Am J Clin Pathol; 2014 Oct; 142(4):492-7. PubMed ID: 25239416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
    Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin generation in vivo and ex vivo in sickle cell disease patients.
    Ladeira VS; de Oliveira Toledo SL; Ferreira LGR; Oliveira MM; Silva APF; de Oliveira WV; Duarte RCF; Renó CO; Dusse LMS; Dos Santos HL; Carvalho MDG; Pinheiro MB; Rios DRA
    Thromb Res; 2021 Jan; 197():165-171. PubMed ID: 33221576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heamostatic and genetic predisposing factors for stroke in children with sickle cell anemia.
    Mourad H; Fadel W; El Batch M; Rowisha M
    Egypt J Immunol; 2008; 15(1):25-37. PubMed ID: 20306667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.